Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection
Abstract
After the incision and drainage of uncomplicated abscesses in adults, treatment with trimethoprim-sulfamethoxazole does not reduce treatment failure but may decrease the formation of subsequent lesions.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
u.s. gov't
non-p.h.s.
adult
female
male
adolescent
aged
middle aged
young adult
risk factors
Randomized Controlled Trial
Double-Blind Method
Multicenter Study
trimethoprim
staphylococcal skin infections / microbiology
staphylococcal skin infections / drug therapy*
anti-infective agents / therapeutic use*
abscess / drug therapy*
drainage
pmid:20346539
doi:10.1016/j.annemergmed.2010.03.002
gillian r schmitz
david bruner
gregory deye
abscess / microbiology
methicillin-resistant staphylococcus aureus*
sulfamethoxazole drug combination / therapeutic use*
Access
Citation
ID:
113894
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
113894
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet